Stent expansion evaluated by optical coherence tomography and subsequent outcomes

Regarding stent expansion indices, previous optical coherence tomography (OCT) studies have shown minimal stent area (MSA) to be most predictive of adverse events. We sought to evaluate the impact of various stent expansion and apposition indices by post-stent OCT on clinical outcomes and find OCT-defined optimal stent implantation criteria. A total of 1071 patients with 1123 native coronary artery lesions treated with new-generation drug-eluting stents with OCT guidance and final post-stent OCT analysis were included. Several stent expansion indices (MSA, MSA/average reference lumen area, MSA/distal reference lumen area, mean stent expansion, and stent expansion by linear model [stent volume/adaptive reference lumen volume]) were evaluated for their association with device-oriented clinical endpoints (DoCE) including cardiac death, target vessel-related myocardial infarction (MI) or stent thrombosis, and target lesion revascularization. MSA was negatively correlated with the risk of DoCE (hazard ratio [HR] 0.80 [0.680.94]). However, stent expansion by linear model representing the overall volumetric stent expansion was associated with greater risk of DoCE (HR 1.02 [1.001.04]). As categorical criteria, MSA<5.0 mm(2) (HR 3.90 [1.997.65]), MSA/distal reference lumen area<90% (HR 2.16 [1.124.19]), and stent expansion by linear model >= 65.0% (HR 1.95 [1.033.89]) were independently associated with DoCE. This OCT study highlights the importance of sufficient stent expansion to achieve adequate, absolute, and relative MSA criteria for improving clinical outcome. It also emphasises that overall volumetric excessive stent expansion may have detrimental effects.

Automated summary

This study evaluated the impact of various stent expansion indices on clinical outcomes and identified optimal stent implantation criteria using optical coherence tomography (OCT). It found that minimal stent area (MSA) was negatively correlated with the risk of adverse events, while overall volumetric stent expansion was associated with greater risk. Categorical criteria, such as MSA<5.0 mm(2), MSA/distal reference lumen area<90%, and stent expansion by linear model>= 65.0%, were independently associated with adverse events.